Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens is a research paper published in PLoS Computational Biology (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01AI50684
National Institute of Health
Grant: U01HL131072
National Institute of Health
Grant: S10OD023524
NIH HHS
Grant: S10 OD026825
National Institutes of Health
Grant: 5U01HL131072-04
A Multi-scale systems pharmacology approach to TB therapy
National Institutes of Health
Grant: 1S10OD023524-01
A QTRAP 6500 LC-MS/MS System from SCIEX for high accuracy drug content analysis
Bill & Melinda Gates Foundation
Wellcome Leap ΔTissue Program
Wellcome Trust
Wellcome Trust
FWCI
1.75
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Identification of novel single nucleotide variants in the drug resistance mechanism of Mycobacterium tuberculosis isolates by whole-genome analysis
Additional file 1 of Identification of novel single nucleotide variants in the drug resistance mechanism of Mycobacterium tuberculosis isolates by whole-genome analysis